hVIVO delivers promising results for Imutex’s mosquito vaccine
AGS-v PLUS contains five synthetic peptides that originate from proteins found in mosquito saliva
Read More
Tag: imutex
Positive in vitro results for Imutex’s FLU-v
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
